28 Mar 22
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland—March 28, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury (SCI), today announces two new innovations have been added to its portfolio of license agreements with the Swiss Federal Institute of Technology Lausanne (EPFL), one of the world’s preeminent neuroscience research institutions, and Lausanne University Hospital (CHUV), ranked among the top 10 hospitals in the world.
21 Mar 22
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland—March 21, 2022—ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces its current cash balance is expected to fuel operations through the end of 2024. The company’s strong cash position will mitigate the impact of industry-wide supply chain challenges that may affect certain development programs.
17 Mar 22
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland—March 17, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces the company will be added to Euronext Brussels’ Bel-Small Index effective 21 March 2022.
09 Mar 22
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland—March 9, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces the start of enrollment in the LIFT Home Study. The trial is designed to study the safety and performance of ARCEX Therapy when used in the home.

Upcoming Events

Recent Presentations